BSFNPTUMZJHOPSFEJO2&% BSFHJWFONPSFTJHOJGJDBODFJO2&11* *UTVHHFTUTUIBU2&11*DBODBQUVSF11*UBSHFUJOHESVHMJLFQSPQFSUJFTDPNQBSFEUP 2&%BOEDBOQMBZBEJGGFSFOUSPMFJOUIFTFFEDPNQPVOEEJTDPWFSZQSPDFTT *OU+.PM4DJ 'JHVSF Int. J. Mol. Sci. 2021, 22, 10925 3 of 15 (a) MW (b) ALogP (c) HBD (d) HBA (e) TPSA (f) ROTB (g) AROM Figure 1. Histograms of seven molecular physicochemical properties for a set of non-redundant compounds of iPPI-DB. Molecular weight (MW) (a), LogP value estimated by Ghose-Crippen method (ALogP) (b), number of hydrogen bond donors (HBD) (c), number of hydrogen bond acceptors (HBA) (d), topological molecular polar surface area (TPSA) (e), number of rotatable bonds (ROTB) (f), and number of aromatic rings (AROM) (g). The solid red lines describe the asymmetric double sigmoid (ADS) function (1) used to model the QEPPI histograms. The black dashed lines describe the ADS function used to model the quantitative estimate of drug-likeness (QED) histograms. Table 1. Distribution peaks and optimized desirability function weightings of each molecular physicochemical property. MW ALogP HBD HBA TPSA ROTB AROM peak QED * 305.8 2.70 1.20 2.38 57.5 3.04 1.8 QEPPI 492.7 4.78 1.61 4.79 76.9 6.37 2.8 wi QED * 0.66 0.46 0.61 0.05 0.06 0.65 0.48 QEPPI 0.47 0.10 0.82 0.81 0.37 0.53 0.89 * QED was modeled as a function that includes ALERTS; the peak value of ALERTS in QED was 24.6, and its weight wALERTS was 0.95. Figure 1 and Table 1 show that oral drugs and PPI-targeting compounds have very different properties. Table 1 shows that the peak values of all properties were higher for Figure 1. Histograms of seven molecular physicochemical properties for a set of non-redundant compounds of iPPI-DB. Molecular weight (MW) (a), LogP value estimated by Ghose-Crippen method (ALogP) (b), number of hydrogen bond donors (HBD) (c), number of hydrogen bond acceptors (HBA) (d), topological molecular polar surface area (TPSA) (e), number of rotatable bonds (ROTB) (f), and number of aromatic rings (AROM) (g). The solid red lines describe the asymmetric double sigmoid (ADS) function (1) used to model the QEPPI histograms. The black dashed lines describe the ADS function used to model the quantitative estimate of drug-likeness (QED) histograms. Table 1. Distribution peaks and optimized desirability function weightings of each molecular physicochemical property. MW ALogP HBD HBA TPSA ROTB AROM peak QED * 305.8 2.70 1.20 2.38 57.5 3.04 1.8 QEPPI 492.7 4.78 1.61 4.79 76.9 6.37 2.8 wi QED * 0.66 0.46 0.61 0.05 0.06 0.65 0.48 QEPPI 0.47 0.10 0.82 0.81 0.37 0.53 0.89 * QED was modeled as a function that includes ALERTS; the peak value of ALERTS in QED was 24.6, and its weight wALERTS was 0.95. Figure 1 and Table 1 show that oral drugs and PPI-targeting compounds have very different properties. Table 1 shows that the peak values of all properties were higher for QEPPI than for QED. Particularly, the major difference between QEPPI and QED is the peak value of ALogP (QEPPI: 4.78, QED: 2.70), suggesting that low lipophilicity and high hydrophilicity are important for oral drugs in terms of oral absorption. This suggests that QEPPI can capture PPI-targeting drug-like properties compared to QED and has a different role in the seed compound discovery process, which is the early-stage of drug discovery. 2.2. Evaluation of QEPPI To evaluate whether QEPPI, which was developed in this study, is a more useful index for early-stage PPI drug discovery compared to QED, we obtained data on 321 PPI- targeting compounds from the iPPI-DB that were not used for model building (iPPI-DB dataset). In addition, we obtained data on 1596 FDA-approved drugs, excluding duplicates and approved drugs targeting PPI (FDA dataset). The QED score was calculated using these data; the distribution of these values is shown in Figure 2a. Similarly, the QEPPI score was calculated, and the distribution of the values is shown in Figure 2b.
black_tank_top
ykamit
lyakaap
yamahiro
tomoaki0705
takehikoihayashi
joisino
tagtag
roadroller
x_ttyszk
mansuy
snhryt
uni_of_nomi
michaelherold
maltzj
mojombo
honnibal
denniskardys
addyosmani
notwaldorf
geoffreycrofte
swwweet
jonrohan
destraynor
orderedlist
